Doxorubicin (DOX) is a potent anti-cancer agent that has garnered great interest in research
due to its high efficacy despite dose-limiting toxicities. Several strategies have been …

Nanovesicles and bio-vesicles (BVs) have emerged as promising tools to achieve targeted
cancer therapy due to their ability to overcome many of the key challenges currently being …

Nowadays, nanotechnology contributes diminishing side effects rather than traditional
therapeutic methods like chemotherapy. Thus, designing a biocompatible specific targeted …

Using nanoparticles to carry and delivery anticancer drugs holds much promise in cancer
therapy, but nanoparticles per se are lacking specificity. Active targeting, that is, using …

Liposomes are among the most well-documented drug delivery systems in anticancer
therapy owing to their passive targeting capacities besides inherent biocompatibility and …

Pharmaceutical nanotechnology introduces novel strategies in designing smart nanoscale
drug delivery systems (NDDSs) capable of responding to specific conditions. These smart …

Aptamers are a class of targeting ligands that bind exclusively to biomarkers of interest.
Aptamers have been identified as candidates for the construction of various smart systems …

In recent years, liposomes have been used in the field of biomedicine and have achieved
many significant results. Because of the unique characteristics of liposomes, there are many …

Despite considerable advances in the application of liposomal drug delivery systems in
cancer treatment, the clinical application of liposomal formulations has been limited by many …

Two important challenges in clinical application of 5-Fluorouracil (5-FU) in the treatment of
colon cancer are preventing the release or degradation of the drug in the stomach/small …